These images are provided for non-commercial use under a Creative Commons License (BY-NC-ND). To license a high resolution version, please contact our image library who will discuss fees, terms and waivers.
Download this imageCreative commons explained - what it means, how you can use our's and other people's content.
Abraham Francen, apothecary
Printmaker: Rembrandt Harmensz. van Rijn
Method of acquisition: Transferred (1876) by Cambridge University Library
Production date: circa AD 1657
IV/X. Printed on Japanese paper.
Support
composed of
Japanese paper
Plate
Height 158 mm
Width 205 mm
Sheet
Height 178 mm
Width 224 mm
Drypoint
Surface tone
Engraving
Etching
Accession number: AD.12.39-186
Primary reference Number: 43864
Hollstein (Dutch/Flemish): B273 IV/X
Biörklund/Barnard: BB57-2 IV/X
Old location number: 38.4.19
Stable URI
Owner or interested party:
The Fitzwilliam Museum
Associated department:
Paintings, Drawings and Prints
This record can be cited in the Harvard Bibliographic style using the text below:
The Fitzwilliam Museum (2024) "Abraham Francen, apothecary" Web page available at: https://collection.beta.fitz.ms/id/object/43864 Accessed: 2024-11-22 00:25:28
To cite this record on Wikipedia you can use this code snippet:
{{cite web|url=https://collection.beta.fitz.ms/id/object/43864
|title=Abraham Francen, apothecary
|author=The Fitzwilliam Museum|accessdate=2024-11-22 00:25:28|publisher=The
University of Cambridge}}
To call these data via our API (remember this needs to be authenticated) you can use this code snippet:
https://collection.beta.fitz.ms/api/v1/objects/object-43864
To use this as a simple code embed, copy this string:
<div class="text-center">
<figure class="figure">
<img src="https://data.fitzmuseum.cam.ac.uk/imagestore/pdp/pdp81/large_AD_12_39_186_1_201802_sjc288_dc2.jpg"
alt="Abraham Francen, apothecary"
class="img-fluid" />
<figcaption class="figure-caption text-info">Abraham Francen, apothecary</figcaption>
</figure>
</div>
Updates about future exhibitions and displays, family activities, virtual events & news. You'll be the first to know...
